在肺癌中用于碳离子治疗的低氧向RBE和OER加权剂量优化
Yazhou Li1, Yuanyuan Ma2, Xinguo Liu2
1Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou 730000, China; Key Laboratory of Heavy Ion Radiation Biology and Medicine of Chinese Academy of Sciences, Lanzhou 730000, China; Gansu Provincial Key Laboratory of Ion Beam Medicine, Lanzhou 730000, China; University of Chinese Academy of Sciences, Beijing 100049, China; Gansu Provincial Hospital, Lanzhou 730000, China.
概括
肺癌的低氧阻碍了放射治疗. 与传统的强度调节碳离子放射治疗 (IMCT) 相比,RBE和OER加权剂量 (ROWD) 优化框架改善了瘤控制概率和减少了肺部并发症.
科学领域:
- 辐射瘤学 辐射瘤学
- 医学物理 医学物理
- 在瘤学瘤学.
背景情况:
- 缺氧在肺癌中很常见,导致治疗耐药性和患者表现不佳.
- 碳离子放射治疗是肺癌的有前途的治疗方式.
- 优化放射性瘤放射治疗计划对于改善治疗疗效至关重要.
研究的目的:
- 评估RBE和OER加权剂量 (ROWD) 优化框架,用于肺癌患者的碳离子放射治疗.
- 为了比较ROWD优化的性能与常规强度调节碳离子放射治疗 (IMCT) 计划.
- 评估ROWD优化的影响,瘤控制概率 (TCP) 和正常组织并发症概率 (NTCP) 在低氧肺瘤.
主要方法:
- 对13名肺癌患者的18F-FMISO PET/CT图像进行了回顾性分析.
- 低氧导向ROWD计划的设计和与IMCT计划的比较,使用剂量-体积直方图 (DVH) 度量,物理剂量分布,剂量平均线性能量转移 (LETd),TCP和NTCP.
- 使用威尔科克森签名等级测试进行对对比的统计分析.
主要成果:
- 在规划瘤总体体积 (PGTV) 时,ROWD优化实现了>95%的处方剂量覆盖率,同时尊重风险器官 (OAR) 约束,即使在缺氧区域.
- 与IMCT相比,ROWD改善了低氧瘤体积 (HTV) 的物理剂量分布,LETd的变化很小.
- 在低氧区域,ROWD计划将瘤控制概率 (TCP) 恢复到76.20% (匹配正常水平),并将肺部并发症NTCP从2.01%降至1.34%,同时保持类似的OAR NTCP.
结论:
- ROWD优化技术显示出显著的潜力,可以提高碳离子放射治疗在低氧区域的肺癌中的疗效.
- ROWD优化提供了一种改进的方法来克服与瘤缺氧相关的治疗阻力.
- 这一框架可能会为接受碳离子放射治疗的肺癌患者带来更好的临床结果.
相关概念视频
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
580
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
580
Hypoxia
1.9K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
1.9K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


